Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06360484
Status:
COMPLETED
Last Update Posted:
2024-04-11
First Post:
2024-04-07
Brief Title:
Prevalence and Clinical Characterization of Hepatitis D Virus HDV Infection Among Sudanese Patients With Hepatitis B Virus
Sponsor:
National Center for Gastroentestinal and Liver Disease
Organization:
National Center for Gastroentestinal and Liver Disease
Study Overview
Official Title:
Prevalence and Clinical Characterization of Hepatitis D Virus HDV Infection Among Sudanese Patients With Hepatitis B Virus HBV A Cross-Sectional Study
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Background Sudan has a high prevalence of hepatitis B surface antigen HBsAg exceeding 8 The prevalence of hepatitis B varies across different regions of Sudan ranging from 68 in central Sudan to as high as 26 in southern Sudan Hepatitis B virus HBV infection can lead to various complications including cirrhosis liver failure and hepatocellular carcinoma HCC Hepatitis D virus HDV relies on HBV for replication and can accelerate the progression of HBV-related liver diseases leading to more severe outcomes This study aims to determine the prevalence of HDV infection among Sudanese patients with HBV-related liver diseases and to investigate the clinical characteristics of patients with HBVHDV co-infection
DesignMethod This descriptive cross-sectional hospital-based study was conducted at Ibn Sina Specialized Hospital in Sudan between June and September 2022 Ninety HBV patients aged 16 years and above were included Patients were interviewed using a structured questionnaire and medical histories and examinations were recorded Investigations included liver function tests abdominal ultrasounds and ELISA for Ant-HDV-IgG
DesignMethod This descriptive cross-sectional hospital-based study was conducted at Ibn Sina Specialized Hospital in Sudan between June and September 2022 Ninety HBV patients aged 16 years and above were included Patients were interviewed using a structured questionnaire and medical histories and examinations were recorded Investigations included liver function tests abdominal ultrasounds and ELISA for Ant-HDV-IgG
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None